Diadia
Our TechnologyResourcesAboutLoginBook a call

© 2026 Diadia. All rights reserved.

About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions
About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions

© 2026 Diadia. All rights reserved.

←Transparency Reports

metabolic · Mechanism Report

Can MTHFD1 rs2236225 AA reduce one-carbon transfer and lead to higher homocysteine and macrocytosis even with normal serum folate?

The MTHFD1 rs2236225 AA genotype destabilizes the enzyme and can reduce folate-dependent one‑carbon transfer capacity, which may raise homocysteine and contribute to macrocytosis despite normal serum folate.

PlausibleJune 19, 202610 Sources

Reasoning Paths

Each route from condition to outcome carries a support score — the product of its edge weights. Select one to isolate it on the figure.

This is what AI claimed

MTHFD1 rs2236225 AA can reduce folate-dependent one-carbon transfer capacity, which can raise homocysteine and contribute to macrocytosis (higher mean corpuscular volume) even when serum folate is normal.

laying out figure…
4 of 6 paths supported
UnsupportedPlausibleSupported

How to read the figure

Evidence state

  • ●EstablishedStrong, replicated evidence.
  • ◐ModerateEvidence-informed; limited or moderate.
  • ◇PlausibleMechanistically coherent, not established.
  • ✕UnsupportedTested and not supported — link breaks.
  • ?MissingNo evidence either way — untested.

Node shapes

  • BiomarkerA measurable state — a lab value, hormone, or genetic factor.
  • ProcessA biological process, pathway, or mechanism step.
  • ConditionA condition, exposure, intervention, or symptom.
  • OutcomeThe endpoint the claim leads to.

Executive summary

The claim states that the AA (G1958A) missense variant impairs MTHFD1 structural stability and catalytic function, lowering intracellular folate‑dependent one‑carbon flux. This reduced capacity limits homocysteine remethylation and nucleotide synthesis, biochemically promoting higher homocysteine and impaired DNA replication that can manifest as increased MCV. The mechanism explains how these effects can occur even when extracellular serum folate appears normal because the defect is in intracellular enzymatic processing.

Verified conclusion

The MTHFD1 rs2236225 (G1958A) polymorphism is a missense mutation in the gene encoding the cytosolic methylenetetrahydrofolate dehydrogenase 1 enzyme, a trifunctional enzyme crucial for one-carbon transfer. This polymorphism results in an arginine-to-glutamine substitution (R653Q) that directly compromises the enzyme's structural stability and catalytic capacity.

Mechanistic explanations

  • Protein Destabilization: Structural modeling demonstrates that the rs2236225 AA genotype significantly destabilizes the MTHFD1 enzyme. This structural vulnerability alters enzyme kinetics and reduces the overall folate-dependent one-carbon transfer capacity (metabolic flux) within the cell.
  • Intracellular vs. Extracellular Folate: Because this genetic variant impairs intracellular enzymatic processing rather than cellular uptake, the reduction in metabolic capacity can occur even when extracellular markers, such as serum folate, appear normal.
  • Downstream Methylation Dynamics: While overall metabolic capacity is strained, studies show that carriers of the A allele (including AA homozygotes) exhibit higher global DNA methylation capacity in blood cells than those with the GG genotype, indicating a complex rerouting of cellular one-carbon intermediates under genetic stress.

Clinical and effectiveness evidence

  • Homocysteine Elevation: Reduced one-carbon transfer capacity directly limits the remethylation of homocysteine back to methionine. When folate-dependent pathway capacity is compromised (especially in states of marginal folate intake), systemic homocysteine levels systematically rise.
  • Macrocytosis Development: The loss of one-carbon transfer efficiency impairs the synthesis of thymidylate and purines. This reduction in nucleotide availability disrupts cellular DNA replication, which is the classical biochemical trigger for megaloblastic macrocytic anemia and an elevated mean corpuscular volume (MCV).

Bottom line

  • The MTHFD1 rs2236225 AA genotype destabilizes the MTHFD1 enzyme and reduces cellular one-carbon transfer capacity, which can biochemically elevate homocysteine and impair DNA synthesis. This impairment can theoretically contribute to macrocytosis even in the presence of normal serum folate levels, although direct clinical isolation of this genetic variant as an independent cause of elevated MCV remains rare in the literature.

References

  1. The negative effect of G1958A polymorphism on MTHFD1 protein stability and HCC growth — link.springer.com ↗
  2. Association between MTHFD1 G1958A Polymorphism and Neural Tube Defects Susceptibility: A Meta-Analysis — dx.plos.org ↗
  3. Common Variants in One-Carbon Metabolism Genes (MTHFR, MTR, MTHFD1) and Depression in Gynecologic Cancers — mdpi.com ↗
  4. One-carbon genetic variants and the role of MTHFD1 1958G>A in liver and colon cancer risk according to global DNA methylation — dx.plos.org ↗
  5. Genetic variants in phosphatidylethanolamine N-methyltransferase (PEMT) and methylenetetrahydrofolate dehydrogenase (MTHFD1) influence biomarkers of choline metabolism when folate intake is restricted — linkinghub.elsevier.com ↗
  6. Mthfd1 Is an Essential Gene in Mice and Alters Biomarkers of Impaired One-carbon Metabolism* — pmc.ncbi.nlm.nih.gov ↗
  7. Independent and Interactive Influences of Environmental UVR, Vitamin D Levels, and Folate Variant MTHFD1-rs2236225 on Homocysteine Levels — mdpi.com ↗
  8. Genetic polymorphisms and folate status — onlinelibrary.wiley.com ↗
  9. Abnormal folate metabolism causes age‐, sex‐ and parent‐of‐origin‐specific haematological defects in mice — pmc.ncbi.nlm.nih.gov ↗
  10. Genetics of homocysteine metabolism and associated disorders. — pmc.ncbi.nlm.nih.gov ↗

See a full patient report verified like this

Book a walkthrough

Related Claims

Plausible8 sourcesDoes the MTHFR rs1801131 A1298C variant mildly reduce enzyme activity and have a smaller homocysteine effect than C677T?→Plausible3 sourcesIs TMAO formed from gut microbial conversion of choline and carnitine followed by liver oxidation?→